Skip to main content
. 2014 Nov 26;176(11):284. doi: 10.1136/vr.102397

TABLEĀ 4:

Reason for withdrawal from or non-completion of the study

Case # Treatment Adverse event ABON* classification
F0102 Mavacoxib Acute spinal injury requiring steroid therapy N
F0308 Mavacoxib Adenocarcinoma involving right kidney N
F0108 Mavacoxib Acute laryngeal paralysis N
F0508 Mavacoxib Idiopathic vestibular syndrome/cerebrovascular accident requiring steroid therapy N
F0401 Mavacoxib Septicaemia, with gastrointestinal ulceration B
F0201 Carprofen Gastrointestinal ulceration A
F0209 Carprofen Gastrointestinal ulceration B
F0403 Carprofen Rodenticide poisoning, owner requested withdrawal N
F0910 Carprofen Idiopathic vestibular syndrome/cerebrovascular accident requiring steroid therapy N
F1107 Carprofen Hepatic lymphoma N
F0907 Carprofen Facial eczema requiring steroid therapy N
F0805 Carprofen Not applicable withdrawn for non-compliance Not applicable

*ABON classification of causality: A=Probable; B=Possible; O=Unclassifiable/unassessable; N=Unlikely